Crossmark

Commentary on early survival gains from adding radiotherapy to ımmunotherapy in bone-metastatic NSCLC

Crossref DOI link: https://doi.org/10.1007/s00432-025-06402-8

Published Online: 2025-12-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Peker, Pınar https://orcid.org/0009-0004-8769-1584
License Information

Text and Data Mining valid from 2025-12-23

Version of Record valid from 2025-12-23
More Information

Article History

Received: 7 November 2025

Accepted: 2 December 2025

First Online: 23 December 2025

Declarations

:

: The authors declare no competing interests.